Clinical Feasibility of the BinaxNOW™ COVID-19/Flu A&B Combo in the Southern Hemisphere
Clinical trial NCT06928129 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06928129
- Sponsor
- Abbott Rapid Dx
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-30
- Primary completion
- 2025-11-01
- Enrollment
- 700
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.